Log in

Angiotensin converting enzyme inhibitor-induced angioedema: a report of two cases

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract 

Angioedema is a rare but potentially fatal side effect of angiotensin converting enzyme (ACE) inhibitors. We report for the first time, two children with systemic lupus erythematosus who developed acute angioedema after the long-term use of enalapril. Prompt recognition and appropriate management of ACE-induced angioedema prevented life-threatening complications. This report highlights the potential risks of angioedema associated with the use of ACE inhibitors in children. Patients should be advised to seek medical treatment immediately if they experience swelling of the face, neck, or tongue, and especially if they have trouble breathing, speaking, or swallowing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 12 March 1999 / Revised: 8 June 1999 / Accepted: 8 June 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Assadi, F., Wang, H., Lawless, S. et al. Angiotensin converting enzyme inhibitor-induced angioedema: a report of two cases. Pediatr Nephrol 13, 917–919 (1999). https://doi.org/10.1007/s004670050727

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004670050727

Navigation